These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37240073)

  • 1.
    Chavarro-Portillo B; Soto CY; Guerrero MI
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenolic glycolipid-1 of Mycobacterium leprae is involved in human Schwann cell line ST8814 neurotoxic phenotype.
    Girardi KDCV; Mietto BS; Dos Anjos Lima K; Atella GC; da Silva DS; Pereira AMR; Rosa PS; Lara FA
    J Neurochem; 2023 Jan; 164(2):158-171. PubMed ID: 36349509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PGL I expression in live bacteria allows activation of a CD206/PPARγ cross-talk that may contribute to successful Mycobacterium leprae colonization of peripheral nerves.
    Díaz Acosta CC; Dias AA; Rosa TLSA; Batista-Silva LR; Rosa PS; Toledo-Pinto TG; Costa FDMR; Lara FA; Rodrigues LS; Mattos KA; Sarno EN; Bozza PT; Guilhot C; de Berrêdo-Pinho M; Pessolani MCV
    PLoS Pathog; 2018 Jul; 14(7):e1007151. PubMed ID: 29979790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycobacterium leprae phenolglycolipid-1 expressed by engineered M. bovis BCG modulates early interaction with human phagocytes.
    Tabouret G; Astarie-Dequeker C; Demangel C; Malaga W; Constant P; Ray A; Honoré N; Bello NF; Perez E; Daffé M; Guilhot C
    PLoS Pathog; 2010 Oct; 6(10):e1001159. PubMed ID: 20975946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reductive Power Generated by
    Rosa TLSA; Marques MAM; DeBoard Z; Hutchins K; Silva CAA; Montague CR; Yuan T; Amaral JJ; Atella GC; Rosa PS; Mattos KA; VanderVen BC; Lahiri R; Sampson NS; Brennan PJ; Belisle JT; Pessolani MCV; Berrêdo-Pinho M
    Front Cell Infect Microbiol; 2021; 11():709972. PubMed ID: 34395315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to phenolic glycolipid-1 and to whole Mycobacterium leprae in leprosy patients: evolution during therapy.
    Bach MA; Wallach D; Flageul B; Hoffenbach A; Cottenot F
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):256-67. PubMed ID: 3522769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcellular localization of Mycobacterium leprae-specific phenolic glycolipid (PGL-I) antigen in human leprosy lesions and in M. leprae isolated from armadillo liver.
    Boddingius J; Dijkman H
    J Gen Microbiol; 1990 Oct; 136(10):2001-12. PubMed ID: 2269873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of phenolic glycolipid I of Mycobacterium leprae in sera from leprosy patients before and after start of multidrug therapy.
    Cho SN; Cellona RV; Villahermosa LG; Fajardo TT; Balagon MV; Abalos RM; Tan EV; Walsh GP; Kim JD; Brennan PJ
    Clin Diagn Lab Immunol; 2001 Jan; 8(1):138-42. PubMed ID: 11139208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for natural antibody in the pathogenesis of leprosy: antibody in nonimmune serum mediates C3 fixation to the Mycobacterium leprae surface and hence phagocytosis by human mononuclear phagocytes.
    Schlesinger LS; Horwitz MA
    Infect Immun; 1994 Jan; 62(1):280-9. PubMed ID: 8262640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Macrophage Response to Mycobacterium leprae Phenolic Glycolipid Initiates Nerve Damage in Leprosy.
    Madigan CA; Cambier CJ; Kelly-Scumpia KM; Scumpia PO; Cheng TY; Zailaa J; Bloom BR; Moody DB; Smale ST; Sagasti A; Modlin RL; Ramakrishnan L
    Cell; 2017 Aug; 170(5):973-985.e10. PubMed ID: 28841420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profile of Rab5, Rab7, tryptophan aspartate-containing coat protein, leprae lipoarabinomannan, and phenolic glycolipid-1 on the failure of the phagolysosome process in macrophages of leprosy patients as a viability marker of Mycobacterium leprae.
    Prakoeswa CR; Wahyuni R; Iswahyudi ; Adriaty D; Yusuf I; Sutjipto ; Agusni I; Izumi S
    Int J Mycobacteriol; 2016 Jun; 5(2):155-63. PubMed ID: 27242226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of Mycobacterium leprae phenolic glycolipid I (PGL-I) in serodiagnosis and in the pathogenesis of leprosy.
    Spencer JS; Brennan PJ
    Lepr Rev; 2011 Dec; 82(4):344-57. PubMed ID: 22439275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of zoonotic leprosy in Pará, Brazilian Amazon, and risks associated with human contact or consumption of armadillos.
    da Silva MB; Portela JM; Li W; Jackson M; Gonzalez-Juarrero M; Hidalgo AS; Belisle JT; Bouth RC; Gobbo AR; Barreto JG; Minervino AHH; Cole ST; Avanzi C; Busso P; Frade MAC; Geluk A; Salgado CG; Spencer JS
    PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006532. PubMed ID: 29953440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Mycobacterium leprae's phenolic glycolipid-I on interferon-gamma augmentation of monocyte oxidative responses.
    Vachula M; Holzer TJ; Kizlaitis L; Andersen BR
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):342-6. PubMed ID: 2165510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological and functional characterizations of Schwann cells stimulated with Mycobacterium leprae.
    Silva TP; Silva AC; Baruque Mda G; Oliveira RB; Machado MP; Sarno EN
    Mem Inst Oswaldo Cruz; 2008 Jun; 103(4):363-9. PubMed ID: 18660991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody response to phenolic glycolipid I and Mycobacterium w antigens and its relation to bacterial load in M. leprae-infected mice and leprosy patients.
    Moudgil KD; Gupta SK; Naraynan PR; Srivastava LM; Mishra RS; Talwar GP
    Clin Exp Immunol; 1989 Nov; 78(2):214-8. PubMed ID: 12412751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of unique Mycobacterium leprae phenolic glycolipid-I (PGL-I) on tumour necrosis factor production by human mononuclear cells.
    Charlab R; Sarno EN; Chatterjee D; Pessolani MC
    Lepr Rev; 2001 Mar; 72(1):63-9. PubMed ID: 11355520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and characterization of peptide mimotopes of phenolic glycolipid-I of Mycobacterium leprae.
    Youn JH; Myung HJ; Liav A; Chatterjee D; Brennan PJ; Choi IH; Cho SN; Shin JS
    FEMS Immunol Med Microbiol; 2004 May; 41(1):51-7. PubMed ID: 15094167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of a specific peptide against phenolic glycolipid-1 from Mycobacterium leprae and its implications in leprosy bacilli entry.
    Arenas NE; Pieffet G; Rocha-Roa C; Guerrero MI
    Mem Inst Oswaldo Cruz; 2022; 117():e220025. PubMed ID: 35857971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgA antibodies against phenolic glycolipid I from Mycobacterium leprae in serum of leprosy patients and contacts: subclass distribution and relation to disease activity.
    Schwerer B; Chujor CS; Bernheimer H; Radl J; Haaijman JJ; Meeker HC; Sersen G; Levis WR
    Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 1):202-11. PubMed ID: 2676273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.